• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Global Dyslipidemia Drug Pipeline Capsule - 2012 Product Image

Global Dyslipidemia Drug Pipeline Capsule - 2012

  • ID: 2011284
  • January 2012
  • Region: Global
  • 15 pages
  • Fore Pharma

Fore Pharma’s latest report ‘Global Dyslipidemia Drug Pipeline Capsule – 2012’ is an outline of all the key research and development (R&D) activities of the global Dyslipidemia drug market. It covers information on key pipeline molecules in various stages of R&D including all the phases of clinical trials, preclinical research, and drug discovery. The report is up-to-date with full coverage of the licensing activities and partnerships.

This report helps executives to keep a track of their competitors and understand their pipeline molecules. The information presented in this report can be used for identifying the partners, prioritizing, evaluating opportunities, developing business development strategies, and executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company and mechanism of action across the different stages of R&D. It includes registered / preregistered stage, phase 3 clinical trial, phase 2 clinical trial, phase 1 clinical trial, preclinical research, and drug discovery. It also provides information on pipeline molecules developed in leading geographies including the READ MORE >

1. Dyslipidemia: Disease Definition
2. Dyslipidemia Drug Pipeline Overview
3. Dyslipidemia Phase 3 Clinical Trial Drug Pipeline Insights
4. Dyslipidemia Phase 2 Clinical Trial Drug Pipeline Insights
5. Dyslipidemia Phase 1 Clinical Trial Drug Pipeline Insights
6. Dyslipidemia Preclinical Research Drug Pipeline Insights
7. Dyslipidemia Drug Discovery Pipeline Insights
8. Geographic Landscape of Dyslipidemia R&D Activities
8.1. Dyslipidemia R&D Activities in North America
8.2. Dyslipidemia R&D Activities in Europe
9. Licensing Activities / Partnerships in the Global Dyslipidemia Drug Market
10. Research Methodology
Table 1: Dyslipidemia Drug Pipeline: Phase 3 Clinical Trial Molecules
Table 2: Dyslipidemia Drug Pipeline: Phase 2 Clinical Trial Molecules
Table 3: Dyslipidemia Drug Pipeline: Phase 1 Clinical Trial Molecules
Table 4: Dyslipidemia Drug Pipeline: Preclinical Research Molecules
Table 5: Dyslipidemia R&D Activities by Geography
Table 6: Dyslipidemia Drug Pipeline: North America
Table 7: Dyslipidemia Drug Pipeline: Europe
Table 8: Dyslipidemia Drug Pipeline: Licensing Activities
Figure 1 : Dyslipidemia Drug Pipeline Molecules by Stages
Figure 2 : Dyslipidemia R&D Activities by Geography

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos